Endothelial nitric oxide synthase-dependent superoxide generation from adriamycin

Jeannette Vásquez-Vivar, Pavel Martasek, Neil Hogg, Bettie Sue Siler Masters, Kirkwood A. Pritchard, B. Kalyanaraman

Research output: Contribution to journalArticle

265 Citations (Scopus)

Abstract

Adriamycin (or doxorubicin) is an active and broad spectrum chemotherapeutic agent. Unfortunately, its clinical use is severely restricted by a dose-limiting cardiotoxicity which has been linked to the formation of superoxide. Enzymatic one-electron reduction of adriamycin forms adriamycin semiquinone radical, which rapidly reacts with oxygen to form superoxide and adriamycin. In this way, adriamycin provides a kinetic mechanism for the one-electron reduction of oxygen by flavoenzymes such as NADPH-cytochrome P450 reductase and mitochondrial NADH dehydrogenase. We demonstrate here that the endothelial isoform of nitric oxide synthase (eNOS) reduces adriamycin to the semiquinone radical. As a consequence, superoxide formation is enhanced and nitric oxide production is decreased. Adriamycin binds to eNOS with a K(m) of approximately 5 μM, as calculated from both eNOS-dependent NADPH consumption and superoxide generation. Adriamycin stimulated superoxide formation is not affected by calcium/calmodulin and is abolished by the flavoenzyme inhibitor, diphenyleneiodonium. This strongly suggests that adriamycin undergoes reduction at the reductase domain of eNOS. A consequence of eNOS-mediated reductive activation of adriamycin is the disruption of the balance between nitric oxide and superoxide. This may lead eNOS to generate peroxynitrite and hydrogen peroxide, potent oxidants implicated in several vascular pathologies.

Original languageEnglish (US)
Pages (from-to)11293-11297
Number of pages5
JournalBiochemistry
Volume36
Issue number38
DOIs
StatePublished - Sep 23 1997

Fingerprint

Nitric Oxide Synthase Type III
Superoxides
Doxorubicin
Nitric Oxide Synthase
Protein Isoforms
Nitric Oxide
Electrons
Oxygen
NADH Dehydrogenase
NADPH-Ferrihemoprotein Reductase
Peroxynitrous Acid
Calmodulin
NADP
Oxidants
Pathology
Hydrogen Peroxide
Blood Vessels
Oxidoreductases
Chemical activation
Calcium

ASJC Scopus subject areas

  • Biochemistry

Cite this

Vásquez-Vivar, J., Martasek, P., Hogg, N., Masters, B. S. S., Pritchard, K. A., & Kalyanaraman, B. (1997). Endothelial nitric oxide synthase-dependent superoxide generation from adriamycin. Biochemistry, 36(38), 11293-11297. https://doi.org/10.1021/bi971475e

Endothelial nitric oxide synthase-dependent superoxide generation from adriamycin. / Vásquez-Vivar, Jeannette; Martasek, Pavel; Hogg, Neil; Masters, Bettie Sue Siler; Pritchard, Kirkwood A.; Kalyanaraman, B.

In: Biochemistry, Vol. 36, No. 38, 23.09.1997, p. 11293-11297.

Research output: Contribution to journalArticle

Vásquez-Vivar, J, Martasek, P, Hogg, N, Masters, BSS, Pritchard, KA & Kalyanaraman, B 1997, 'Endothelial nitric oxide synthase-dependent superoxide generation from adriamycin', Biochemistry, vol. 36, no. 38, pp. 11293-11297. https://doi.org/10.1021/bi971475e
Vásquez-Vivar J, Martasek P, Hogg N, Masters BSS, Pritchard KA, Kalyanaraman B. Endothelial nitric oxide synthase-dependent superoxide generation from adriamycin. Biochemistry. 1997 Sep 23;36(38):11293-11297. https://doi.org/10.1021/bi971475e
Vásquez-Vivar, Jeannette ; Martasek, Pavel ; Hogg, Neil ; Masters, Bettie Sue Siler ; Pritchard, Kirkwood A. ; Kalyanaraman, B. / Endothelial nitric oxide synthase-dependent superoxide generation from adriamycin. In: Biochemistry. 1997 ; Vol. 36, No. 38. pp. 11293-11297.
@article{bbd2bdb9039c4483aeeab20c0a6eaf20,
title = "Endothelial nitric oxide synthase-dependent superoxide generation from adriamycin",
abstract = "Adriamycin (or doxorubicin) is an active and broad spectrum chemotherapeutic agent. Unfortunately, its clinical use is severely restricted by a dose-limiting cardiotoxicity which has been linked to the formation of superoxide. Enzymatic one-electron reduction of adriamycin forms adriamycin semiquinone radical, which rapidly reacts with oxygen to form superoxide and adriamycin. In this way, adriamycin provides a kinetic mechanism for the one-electron reduction of oxygen by flavoenzymes such as NADPH-cytochrome P450 reductase and mitochondrial NADH dehydrogenase. We demonstrate here that the endothelial isoform of nitric oxide synthase (eNOS) reduces adriamycin to the semiquinone radical. As a consequence, superoxide formation is enhanced and nitric oxide production is decreased. Adriamycin binds to eNOS with a K(m) of approximately 5 μM, as calculated from both eNOS-dependent NADPH consumption and superoxide generation. Adriamycin stimulated superoxide formation is not affected by calcium/calmodulin and is abolished by the flavoenzyme inhibitor, diphenyleneiodonium. This strongly suggests that adriamycin undergoes reduction at the reductase domain of eNOS. A consequence of eNOS-mediated reductive activation of adriamycin is the disruption of the balance between nitric oxide and superoxide. This may lead eNOS to generate peroxynitrite and hydrogen peroxide, potent oxidants implicated in several vascular pathologies.",
author = "Jeannette V{\'a}squez-Vivar and Pavel Martasek and Neil Hogg and Masters, {Bettie Sue Siler} and Pritchard, {Kirkwood A.} and B. Kalyanaraman",
year = "1997",
month = "9",
day = "23",
doi = "10.1021/bi971475e",
language = "English (US)",
volume = "36",
pages = "11293--11297",
journal = "Biochemistry",
issn = "0006-2960",
publisher = "American Chemical Society",
number = "38",

}

TY - JOUR

T1 - Endothelial nitric oxide synthase-dependent superoxide generation from adriamycin

AU - Vásquez-Vivar, Jeannette

AU - Martasek, Pavel

AU - Hogg, Neil

AU - Masters, Bettie Sue Siler

AU - Pritchard, Kirkwood A.

AU - Kalyanaraman, B.

PY - 1997/9/23

Y1 - 1997/9/23

N2 - Adriamycin (or doxorubicin) is an active and broad spectrum chemotherapeutic agent. Unfortunately, its clinical use is severely restricted by a dose-limiting cardiotoxicity which has been linked to the formation of superoxide. Enzymatic one-electron reduction of adriamycin forms adriamycin semiquinone radical, which rapidly reacts with oxygen to form superoxide and adriamycin. In this way, adriamycin provides a kinetic mechanism for the one-electron reduction of oxygen by flavoenzymes such as NADPH-cytochrome P450 reductase and mitochondrial NADH dehydrogenase. We demonstrate here that the endothelial isoform of nitric oxide synthase (eNOS) reduces adriamycin to the semiquinone radical. As a consequence, superoxide formation is enhanced and nitric oxide production is decreased. Adriamycin binds to eNOS with a K(m) of approximately 5 μM, as calculated from both eNOS-dependent NADPH consumption and superoxide generation. Adriamycin stimulated superoxide formation is not affected by calcium/calmodulin and is abolished by the flavoenzyme inhibitor, diphenyleneiodonium. This strongly suggests that adriamycin undergoes reduction at the reductase domain of eNOS. A consequence of eNOS-mediated reductive activation of adriamycin is the disruption of the balance between nitric oxide and superoxide. This may lead eNOS to generate peroxynitrite and hydrogen peroxide, potent oxidants implicated in several vascular pathologies.

AB - Adriamycin (or doxorubicin) is an active and broad spectrum chemotherapeutic agent. Unfortunately, its clinical use is severely restricted by a dose-limiting cardiotoxicity which has been linked to the formation of superoxide. Enzymatic one-electron reduction of adriamycin forms adriamycin semiquinone radical, which rapidly reacts with oxygen to form superoxide and adriamycin. In this way, adriamycin provides a kinetic mechanism for the one-electron reduction of oxygen by flavoenzymes such as NADPH-cytochrome P450 reductase and mitochondrial NADH dehydrogenase. We demonstrate here that the endothelial isoform of nitric oxide synthase (eNOS) reduces adriamycin to the semiquinone radical. As a consequence, superoxide formation is enhanced and nitric oxide production is decreased. Adriamycin binds to eNOS with a K(m) of approximately 5 μM, as calculated from both eNOS-dependent NADPH consumption and superoxide generation. Adriamycin stimulated superoxide formation is not affected by calcium/calmodulin and is abolished by the flavoenzyme inhibitor, diphenyleneiodonium. This strongly suggests that adriamycin undergoes reduction at the reductase domain of eNOS. A consequence of eNOS-mediated reductive activation of adriamycin is the disruption of the balance between nitric oxide and superoxide. This may lead eNOS to generate peroxynitrite and hydrogen peroxide, potent oxidants implicated in several vascular pathologies.

UR - http://www.scopus.com/inward/record.url?scp=19244383998&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=19244383998&partnerID=8YFLogxK

U2 - 10.1021/bi971475e

DO - 10.1021/bi971475e

M3 - Article

C2 - 9333325

AN - SCOPUS:19244383998

VL - 36

SP - 11293

EP - 11297

JO - Biochemistry

JF - Biochemistry

SN - 0006-2960

IS - 38

ER -